TrialCancer discovery2018

The Genetic Landscape and Clonal Evolution of Breast Cancer Resistance to Palbociclib plus Fulvestrant in the PALOMA-3 Trial.

Ben O'Leary et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.